Press Releases April 30, 2026 06:30 AM

Ducommun to Participate in BofA Securities 33rd Annual Industrials, Transportation & Airlines Key Leaders Conference

Ducommun Executives to Present at BofA Securities Annual Industrials Conference

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
DCO

Ducommun Incorporated announced that its senior financial executives will present at the BofA Securities 33rd Annual Industrials, Transportation & Airlines Key Leaders Conference. The event will feature a general presentation and one-on-one investor meetings, with materials and a webcast accessible via the company's website. Ducommun specializes in aerospace, defense, and industrial manufacturing solutions, focusing on electronic and structural systems.

Ducommun to Participate in BofA Securities 33rd Annual Industrials, Transportation & Airlines Key Leaders Conference
DCO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Ducommun executives to present corporate updates at a major industry conference on May 14, 2026.
  • The company serves aerospace, defense, and industrial markets with specialized electronic and structural systems.
  • Presentation materials and webcast will be shared publicly, providing insight to investors and stakeholders.

COSTA MESA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) announced today that Suman Mookerji, the Company’s senior vice president and chief financial officer, and Christian Prezgay, vice president of financial planning and analysis and investor relations, will participate in the upcoming BofA Securities 33rd Annual Industrials, Transportation & Airlines Key Leaders Conference on May 14, 2026. A general presentation will be held at 11:05 a.m. Eastern, with one-on-one investor meetings scheduled throughout the day.

Additional information will be posted on the Company’s website at www.ducommun.com when available, including a copy of any presentation material. A live webcast of the presentation can be accessed using this link. A replay of the webcast will be available on the Ducommun website at www.ducommun.com. Institutional investors are welcome to contact BofA Securities to arrange one-on-one meetings with management.

About Ducommun Incorporated
Ducommun Incorporated delivers value-added innovative products and manufacturing solutions to customers in the aerospace, defense, and industrial markets. Founded in 1849, the Company specializes in two core areas - Electronic Systems and Structural Systems - to produce complex products and components for commercial aircraft platforms, mission-critical military and space programs, and sophisticated industrial applications. For more information, visit www.ducommun.com.

Contacts
Suman Mookerji, Senior Vice President & Chief Financial Officer
657.335.3665, SMookerji@ducommun.com


Risks

  • Market reaction is uncertain as the announcement is informational without new financial guidance or material business updates.
  • Performance depends on aerospace, defense, and industrial sectors which can be affected by geopolitical and economic factors.
  • Potential volatility exists if investor meetings reveal unexpected operational or financial challenges.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026